Dr. Werner has over 25 years of experience building integrated software solutions for US pharmaceutical manufacturers, and is a recognized expert in many areas of business processing, including chargebacks, Government Pricing, Medicaid, Coverage Gap, Tricare, EDI, Purchase Orders. He presented results of his studies on many aspects of processing as a speaker at numerous pharmaceutical conferences.
Alexander's technical specialization is in managing large databases and Business Intelligence systems. MSDN publiched some results of his software studies on object-oriented programming.
Alexander earned his Ph. D. in Computer Science field of Data Modeling, and M.Sc. in Math Summa Cum Laude.
For over 17 years, he personally designed and supervised the implementation of Relasoft Pharma Suite for The Harvard Drug Group, the second largest distributor of generics products at the time, and its sister company Major Pharmaceuticals.
Software designed by Dr. Werner saved many of his clients hundreds of thousands of dollars by preventing over-payments and greatly increasing staff efficiency.
40+ years in the Pharmaceutical Industry with a Master’s Degree in Marketing, Ben graduated from the Univ. of Florida with a degree in Business, and then Fairleigh Dickenson Univ., with a Masters. Ben’s background includes all aspects of the commercial and distribution sides of the pharmaceutical industry, starting in the retail pharmacy business, he moved to the wholesale side where he completed a management trainee program and then launching one of the first private label generic pharmaceutical lines in the country.
Switching sides of the desk, Ben took a sales position with a national generic pharma company, Geneva Generics, and then after obtaining his Masters, moved into medical advertising working with two small agencies in the NYC area. After a couple of years, Ben started working with Taro Pharmaceuticals as their first sales person and helped launch them nationally building both a sales and marketing organization under him.
From that point on, Ben remained on the sales side working with various companies as he moved from rep, TARO, to head of sales and marketing, Taro and Alpharma, and then to owning his own specialty repackaging company, Republic Drug. After closing that company, he worked as an independent consultant helping to launch or reset multiple pharmaceutical companies and products, both brand and generic. Some of his clients were Reliant Pharmaceuticals, Endo, Eisai, Triax, Akrimax, Rouses Point, Epic, Edenbridge and eventually Masters Pharmaceutical, where he established and ran a third-party company, RxTPL which eventually was purchased by McKesson Drug.
Yehuda has spent decades architecting go-to-market and marketing strategies that transform how SaaS companies scale across North America.
His approach centers on understanding the unique competitive landscape each company faces, then crafting precise market entry and revenue acceleration strategies that deliver measurable outcomes. Throughout his career, he has worked at the intersection of strategy and execution, whether guiding venture-backed startups through their first major growth phases or helping established enterprises navigate complex market expansions.
His methodology combines deep market analysis with hands-on implementation, creating sustainable growth engines that perform long after initial deployment.
Oleg Amurjuev has an incredibly varied experiences and background in senior management within high-tech industry (computer hardware and software), management consulting, teaching and mentoring. Oleg Amurjuev’s personal mission is to make entrepreneurs and managers of start-up and early-stage companies knowledgeable about the most efficient processes for turning an idea into a successful business, be it development of the commercialization strategy, corporate structure creation, or raising venture capital. He is a part-time Instructor and Facilitator at the Schulich Executive Education Centre, focusing on corporate governance, business planning and technology commercialization.